South Orange, NJ

Northern New Jersey Eye Institute

Open-Angle Glaucoma

Ocular Hypertension

Dry Eye Syndromes

Conjunctivitis

Glaucoma

Hypertension

Bacterial Conjunctivitis

Presbyopia

Cataract

Inclusion Conjunctivitis

Timolol Maleate

DE-126

iodine

DE-117

AGN-193408

Iodine

Travoprost

Povidone

AbbVie

Glaukos

Santen

Shire

Bausch + Lomb

BioTissue Holdings, Inc

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

This is a multicenter, open-label, dose escalation (Cohort 1) to masked, randomized, parallel-groups (Cohort 2) and (Cohort 3) study to evaluate the safety and efficacy of AGN-193408 SR in participants with open-angle glaucoma or ocular hypertension

AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension

Northern New Jersey Eye Institute | South Orange, NJ

Site insights

Work at this site?

Active trials

AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension

Trial sponsors